In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
After taking center stage in “Hamilton,” Javier Muñoz reflects on his HIV journey.
Front row at GMHC’s Latex Ball
National, state and local races will affect HIV prevention, care and treatment—both at home and abroad.
Evaluate HIV-related issues in the 2016 election.
HIV-related insights on the 2016 election.
Much is at stake in this election. The results up and down the ballot will directly affect HIV prevention, care and treatment.
UMMA Community Clinic marks 20 years serving the Muslim and Latino communities of South Los Angeles.
Daniel D. Driffin speaks about HIV at the DNC.
Elleder and his team reconstructed ancient viral genomes, dating the oldest lentiviruses to as long ago as 60 million years.
A new movement to update laws that criminalize HIV
A group for HIV-positive Muslims holds its first retreat.
A video campaign gives voice to trans women and HIV.
“To prevent HIV, we need more outreach,” Duckett says. “I would have never gotten sick had I gotten tested and treated.
POZ readers weigh in on the option of filtering by HIV status on the gay dating app Grindr.
Spreading the word about the “negligible risk” of transmitting HIV
Cecilia Aldarondo—a native of Orlando and the director of Memories of a Penitent Heart—reflects on the sanctuary of gay clubs.
A peek at some of the social media buzz.
HIV-positive breast-feeding mothers can nearly eliminate the risk of transmitting HIV to their babies by taking ARVs.
Mass imprisonment of drug users worldwide, as well as a scarcity of harm reduction programs, contributes to the spread of HIV.
The HPTN 052 trial found no transmissions between mixed-HIV-status heterosexual couples when the HIV-positive partner was undetectable.
New findings from the PARTNER trial saw no transmissions within the couples, underlining the power of ARVs to curb the spread of HIV.
Women who used the monthly ring at high levels benefited from a significant HIV risk reduction.
A long-acting injectable HIV regimen dosed every four weeks is slated to advance to Phase III trials in late 2016.
The U.S. President’s Emergency Plan for AIDS Relief gives aid disproportionately to countries with epidemics generalized across risk groups.
Scientists have created a consortium to help them better understand and potentially achieve a cure based on stem cell transplants.
HIV-related discrimination is among the top barriers to HIV prevention, treatment, care and support. Here are your responses to our survey.
Through educating herself about HIV, Arianna Lint learned to shed the self-stigma she felt and became determined to live out loud.